From sauna blankets and high-tech sleep systems, to red light and recovery, these are worth considering working into your ...

From sauna blankets and high-tech sleep systems, to red light and recovery, these are worth considering working into your routine.

Provincial Key Laboratory of Biotechnology of Shaanxi, Key Laboratory of Resource Biology and Modern Biotechnology in Western China, Faculty of Life Science, Northwest University, 229 North Taibai ...

Tyler Perry reminds us that starting therapy is never too late. The director was recently a guest on The View and revealed that he began therapy for the first time at 54. Perry said a question ...

Akamis Bio, a clinical-stage oncology company, has raised $60 million in Series A funding that will drive continued development of NG-350A, a new gene therapy based on its proprietary tumor ...

While I’m not a substitute for professional therapy, I can offer comforting advice, coping strategies, and a safe, judgment-free space to express yourself. How are you feeling today?” ...

Bioresonance is a type of therapy used in holistic or complementary medicine. However, there’s no sound scientific evidence that bioresonance has a role in diagnosing or treating disease.

Tenaya Therapeutics on Tuesday released early findings from the Phase Ib/II MyPEAK-1 study, demonstrating what it called “robust” delivery of its investigational gene therapy TN-201 into the heart ...

Last year, Microsoft discontinued its long running line of PC hardware accessories which had ranged from countless mice, keyboards, and audio peripherals over the years. Not all was lost ...

As former director of the U.S. National Cancer Institute (NCI), Dr Klausner was instrumental in advancing CAR-T therapy and shaping the nation's cancer research agenda. "bit.bio is one of the ...

Ozone therapy, Bio-resonance bioenergetic therapy, supported by its in-house functional medicine doctor. One’s healthness journey at the clinic begins with a comprehensive consultation led by a ...

Editas on Thursday kicked off a cost-cutting transition initiative after its hunt for a development sponsor for its sickle cell disease therapy renizgamglogene autogedtemcel turned up empty. As part ...